Global Right Ventricular Assist Device Market Growth 2025-2031

The global Right Ventricular Assist Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

A Right Ventricular Assist Device (RVAD) is a medical device used to support the function of the right ventricle of the heart. It is typically used in cases of severe heart failure when the right ventricle is unable to pump blood effectively, helping to improve cardiac output while the patient awaits a heart transplant or recovers from cardiac surgery.

LP Information, Inc. (LPI) ' newest research report, the “Right Ventricular Assist Device Industry Forecast” looks at past sales and reviews total world Right Ventricular Assist Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Right Ventricular Assist Device sales for 2025 through 2031. With Right Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Right Ventricular Assist Device industry.

This Insight Report provides a comprehensive analysis of the global Right Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Right Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Right Ventricular Assist Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Right Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Right Ventricular Assist Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Right Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Destination Therapy

Bridge to Transplantation

Bridge to Recovery

Bridge to Destination

Segmentation by Application:

Hospitals

Cardiology Centers

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Abbott

Abiomed

Berlin Heart

Thoratec

Jarvik Heart

HeartWare

Apaxis

CorWave

Evaheart

Reliantheart

Key Questions Addressed in this Report

What is the 10-year outlook for the global Right Ventricular Assist Device market?

What factors are driving Right Ventricular Assist Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Right Ventricular Assist Device market opportunities vary by end market size?

How does Right Ventricular Assist Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more